跳至主要内容
临床试验/EUCTR2018-000748-24-NL
EUCTR2018-000748-24-NL进行中(未招募)1 期

Partial neuromuscular blockade to facilitate lung and diaphragm protectivemechanical ventilation in ICU patients.A randomized controlled pilot study.

VUmc0 个研究点目标入组 30 人开始时间: 2018年6月27日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
VUmc
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients are eligible for inclusion if they meet all of the following
  • - high respiratory drive, defined as tidal volume > 8ml/kg PBW on
  • inspiratory support of 12cmH2O.
  • - sedation level: RASS = -3
  • - ventilated in pressure support mode
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 15
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 15

排除标准

  • A potential subject who meets any of the following criteria will be
  • excluded from participation in this study:
  • - recent use of NMBA (< 2 hrs)
  • - arterial pH < 7.25
  • - hemodynamic instability, i.e. high dose vasopressors (>0.5 µg/kg/min)
  • or inotropes (dobutamine >15 µg/kg/min or enoximone >25
  • - intracranial pressure > 20 cmH2O
  • - past medical history of neuromuscular disorders
  • - pregnancy
  • - known previous anaphylactic reaction to NMBA's.

研究者

发起方
VUmc

相似试验